EUSA Pharma
Martin Herold possesses extensive experience in the pharmaceutical and medical fields, currently serving as a Medical Science Liaison specializing in Oncology and Rare Diseases at EUSA Pharma since November 2020. Prior roles include an Oncology & Rare Disease Specialist and a Pharmareferent in scientific field service at Berlin-Chemie AG, focusing on diabetes, asthma/COPD, cardiology, and gout from April 2015 to October 2020. Additionally, Martin briefly worked as a scientific employee at Biomedro GmbH, where responsibilities included production and quality assurance of laboratory diagnostics. Academic credentials include a Dr. rer. nat. in Molecular Biology and a Diplom in Molecular Biology from Justus-Liebig-Universität Gießen. Early career experience includes serving as a snowboard trainer at Skischule Winterberg from 2000 to 2008.
This person is not in any offices
EUSA Pharma
1 followers
We are committed to transforming the lives of people affected by cancer or rare disease, globally. We continuously strive to uncover opportunities which address gaps across adult and paediatric care. Helping the people with few or no options available is at the heart of everything we do. EUSA Pharma is part of Recordati Rare Diseases (recordatirarediseases.com), the business unit dedicated to rare disease in the Recordati group. Recordati has a total staff of more than 4,300, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. More information can be found in the press release: https://www.recordati.com/resources/Pubblicazione/___58a6bc05f57c4861aae203c930cd1682_/eusa-closing-pr.pdf We see a need. We work together. We don’t give up.